Please assess the completion status of the following clinical trial:

Trial Title: Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion criteria:~* Histologically confirmed Adenocarcinoma of the rectum (up to 10 cm from the anal verge)~* International Union Against Cancer stages II or III~* ECOG PS 0/2~* Informed consent~Exclusion Criteria:~* Congestive heart failure (NYHA III/IV)~* History of myocardial infarction within the last 6 months.~* AV Block III~* Total hip replacement or major metal pelvic implants~* Cardiac pacemaker~* Contraindications for radiochemotherapy~* Contraindications for surgical tumor resection~* Previous pelvic radiotherapy or chemotherapy~* Active chronic inflammatory bowel disease~* Collagenosis~* Congenital diseases with increased radiosensitivity~* Pregnancy or breastfeeding~* Secondary malignancies other than locally controlled basalioma or in-situ carcinomas Infiltration of the anal canal

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- RtChx + Hyperthermia (Type: EXPERIMENTAL): Radiotherapy: 5 x 1,8 Gy/Week, cumulative dose 50,4 Gy (ICRU) Chemotherapy: 5-fluorouracil d1-5 and d29-d33 Deep regional hyperthermia: 2x/week

Based on this trial design, predict the completion outcome and termination type (if applicable).